Incyte Cash Flow Statement
INCY / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Incyte generated $1.4B in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $1.3B | $32.6M | $597.6M | $340.7M | $948.6M | -$295.7M | $446.9M | $109.5M | -$313.1M | $104.2M | - | - | - | - | - |
| Depreciation & Amortization | $93.3M | $89.2M | $82.7M | $67.9M | $57.8M | $51.8M | $54.5M | $55.0M | $52.2M | $58.4M | $44.9M | $41.4M | $29.2M | $30.0M | $27.0M |
| Operating Cash Flow | $1.4B | $335.3M | $496.5M | $969.9M | $749.5M | -$124.6M | $710.7M | $336.2M | -$93.0M | $304.8M | $89.4M | $26.3M | $9.2M | -$94.8M | -$161.7M |
| Capital Expenditures | - | $48.7M | - | $77.8M | $181.0M | $187.4M | $78.1M | $73.5M | $111.0M | $120.3M | $26.0M | $27.9M | $4.3M | $2.8M | $3.8M |
| Free Cash Flow | - | $286.6M | - | $892.1M | $568.5M | -$312.0M | $632.6M | $262.7M | -$204.0M | $184.5M | $63.4M | -$1.6M | $4.9M | -$97.7M | -$165.5M |
| Share Buybacks | $0 | $2.0B | $0 | $0 | - | - | - | - | - | - | - | - | - | - | - |
| FCF Margin | - | 6.8% | - | 26.3% | 19.0% | -11.7% | 29.3% | 14.0% | -13.3% | 16.7% | 8.4% | -0.3% | 1.4% | -32.9% | -175.2% |